Medical Equipment

Global Cancer Biomarker Market Size and Forecast to 2029: Revenue, Growth, and Trends

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cancer biomarker market from 2025–2034 with trusted insights from The Business Research Company

How Big Is The Cancer Biomarker Market Size Today And What Will Its Value Be At The End Of 2029?

The cancer biomarker market has experienced substantial growth in recent years. It is forecast to expand from $22.19 billion in 2024 to $25.09 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 13.1%. This historical expansion can be attributed to the shift towards personalized medicine, innovations in immunotherapy, the evolution of regulatory frameworks, collaborative research efforts, and a heightened focus on non-coding RNAs.

The cancer biomarker market is anticipated to experience substantial expansion over the upcoming years. This market is predicted to reach $45.33 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 15.9%. This expansion during the forecast timeframe is attributable to a move towards patient-focused diagnostics, the incorporation of biomarkers into clinical trials, the rise of multiplex biomarker panels, the investigation of non-coding RNAs, and the broader availability of biomarker tests. Key developments expected within this period encompass progress in genomics, personalized medicine strategies, liquid biopsy techniques, innovations in immunotherapy, and the adoption of artificial intelligence (AI).

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8492&type=smp

Which Key Drivers Are Powering Growth In The Cancer Biomarker Market?

The growing occurrence of cancer is a key factor propelling the expansion of the cancer biomarker market. This rate refers to the count of new cancer cases, specific to a site or type, observed within a particular population over a year, expressed as cancers per 100,000 individuals at risk. Consequently, the increased prevalence of cancer is fostering the extensive adoption of cancer biomarkers, which prove instrumental in evaluating disease risk, screening for hidden primary tumors, distinguishing between benign and malignant indicators, and differentiating various forms of malignancy. As an illustration, in January 2022, the American Cancer Society, a US-based health organization, published research indicating that the US is projected to see 609,360 cancer deaths and 1.9 million new cancer cases in 2022. This translates to approximately 1,670 fatalities daily. Consequently, the escalating occurrence of cancer is forecasted to boost the expansion of the cancer biomarker market in the forthcoming years.

Which Segment Categories Are Driving Maximum Growth In The Cancer Biomarker Market?

The cancer biomarkermarket covered in this report is segmented –

1) By Biomarkers Type: Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers

2) By Profiling Technologies: Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Cytogenetics

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Other Cancers

4) By Application: Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications

Subsegments:

1) By Protein Biomarkers: Tumor-Specific Antigens, Circulating Tumor Protein

2) By Genetic Biomarkers: DNA Mutations, RNA Expression Profiles

3) By Other Cancer Biomarkers: Epigenetic Biomarkers, Metabolomic Biomarkers

What Key Trends Are Driving Growth In The Cancer Biomarker Market?

Leading companies within the cancer biomarker market are focused on developing groundbreaking solutions, such as AI-driven cancer biomarkers, to improve diagnostic precision and personalize treatment approaches for patients. AI-powered cancer biomarkers are defined as biological indicators of cancer that are identified and analyzed using artificial intelligence technologies. As an illustration, in September 2023, Ibex Medical Analytics, a US-based firm, introduced Galen Breast HER2, an AI-powered solution crafted to elevate the accuracy and reproducibility of HER2 scoring in breast cancer patients. This innovative platform supports pathologists by automatically detecting invasive tumor regions and quantifying HER2 expression in line with the 2018 ASCO/CAP guidelines. The Galen Breast HER2 system utilizes a novel computational pipeline to analyze immunohistochemistry (IHC)-stained slides, delivering detailed visualizations of staining patterns and enabling pathologists to make informed treatment decisions.

Who Are The Leading Companies Driving The Cancer Biomarker Market?

Major companies operating in the cancer biomarker market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., QIAGEN NV, Illumina Inc., Bio-Rad Laboratories Inc., Abbott Laboratories, bioMérieux SA, Becton Dickinson and Company, Merck & Co. Inc., Bristol-Myers Squibb Company, PerkinElmer Inc., Siemens AG, Exact Sciences Corporation, Novartis AG, Agilent Technologies Inc., Hologic Inc., Myriad Genetics Inc., Foundation Medicine Inc., Guardant Health Inc., Natera Inc., Sysmex Corporation, Biocartis Group NV, NanoString Technologies Inc., Veracyte Inc., Epic Sciences Inc., Cynvenio Biosystems Inc., Genomic Health Inc., Oncocyte Corporation, Exosome Diagnostics Inc., Grail Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

Which Region Holds The Largest Share In The Cancer Biomarker Market Today?

North America was the largest region in the cancer biomaker market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer biomarker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=8492&type=smp

Browse Through More Reports Similar to the Global Cancer Biomarker Market 2025, By The Business Research Company

Pain Management Devices And Therapies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pain-management-devices-and-therapies-global-market-report

Metabolomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

Isothermal Nucleic Acid Amplification Technology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/isothermal-nucleic-acid-amplification-technology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795